Exercise and fatigue in myasthenia gravis – how to assess fatigue and advise on exercise?

Neuromuscular Academy will host a live webinar on January 23rd at 16:00. You are invited to watch the webinar from your computer or tablet. We will be live for 1 hour and 35 minutes via Zoom and a recording of the Neuromuscular Academy session will be available following the meeting.

16:00 - 16:45 - Neuromuscular Academy session
16:45 - 16:50 - Break
16:50 - 17:35 - argenx promotional satellite symposium

Neuromuscular Academy session

Join our webinar to deepen your understanding of fatigue management in Myasthenia Gravis (MG). Discover how to differentiate fatigue from fatigability, use the right tools to assess its impact, and learn why tailored exercise programs are essential for improving strength, endurance, and quality of life in MG patients.

Webinar objectives

• Recognising fatigue in patients with MG and distinguishing from fatigability.
• Measuring fatigue - finding the right tool.
• Managing fatigue - the importance of exercise for all MG patients.

This webinar has received sponsorship from argenx UK limited. The first session in the webinar is designed and delivered by the Neurology Academy and sponsored by argenx UK limited; the sponsor has had no input into the educational content or organisation of the session. The second session is a promotional satellite symposium that is organised and funded by argenx UK limited. This satellite symposium is for UK Healthcare Professionals only.

argenx UK limited promotional satellite symposium:
Regional MDTs in Myasthenia Gravis: Building Pathways for Better Patient Care

Join leading healthcare professionals as they explore the crucial role of Regional Multidisciplinary Teams (MDTs) in transforming Myasthenia Gravis care. This interactive webinar showcases the successful Yorkshire pathway model and provides practical insights into implementing effective MDT frameworks. Through case studies, expert discussions and real patient experiences, discover how regional MDTs can enhance patient outcomes and optimise care delivery. Argenx products will be discussed.

Learning Objectives: By the end of this webinar, delegates will:

• Understand the rationale and benefits of establishing Regional MDTs for Myasthenia Gravis care
• Gain practical insights into implementing a Regional MDT pathway through the Yorkshire exemplar
• Learn from real-world case studies and patient experiences in MDT-based care
• Identify key strategies for successful MDT collaboration and patient management
• Develop an understanding of how to integrate MDT approaches into their own practice settings

UK-EFG-24-00093
Date of Prep: December 2024

This event is free to attend as a result of sponsorship from our sponsors. The current event sponsors are listed on this page. In the interest of Neurology Academy and our sponsors’ legitimate business interests, we make available your name, job title and workplace to our sponsors. It allows us to attract the most appropriate sponsors, delegates and speakers for the events and to facilitate potential collaboration and communication between you and the sponsors; and allows us to offer other relevant events and services to the healthcare and life science industries. You can ask us not to share your name, job title and workplace by emailing info@neurologyacademy.org. We respect the privacy of every person for whom we have personal data. The group privacy and cookies policy can be viewed here.